Amplitudes and kinetic of antibodies after second and third doses of BNT162b2 vaccine in nonagenarians and centenarians with and without prior SARS-CoV-2 infection

Clin Microbiol Infect. 2022 Oct;28(10):1393-1395. doi: 10.1016/j.cmi.2022.05.025. Epub 2022 May 31.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged, 80 and over
  • Antibodies
  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19* / prevention & control
  • Centenarians
  • Humans
  • Nonagenarians
  • SARS-CoV-2
  • Vaccines*

Substances

  • Antibodies
  • Antibodies, Viral
  • Vaccines
  • BNT162 Vaccine